1-(4-benzoylpiperazin-1-yl)-2-(4-methoxy-1H-pyrrolo[2,3-b]pyridin-3-yl)ethane-1,2-dione

ID: ALA5204063

Chembl Id: CHEMBL5204063

PubChem CID: 68083605

Max Phase: Preclinical

Molecular Formula: C21H20N4O4

Molecular Weight: 392.42

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1ccnc2[nH]cc(C(=O)C(=O)N3CCN(C(=O)c4ccccc4)CC3)c12

Standard InChI:  InChI=1S/C21H20N4O4/c1-29-16-7-8-22-19-17(16)15(13-23-19)18(26)21(28)25-11-9-24(10-12-25)20(27)14-5-3-2-4-6-14/h2-8,13H,9-12H2,1H3,(H,22,23)

Standard InChI Key:  XRIAXBXIFGJSJO-UHFFFAOYSA-N

Associated Targets(non-human)

env Envelope glycoprotein gp160 (755 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 392.42Molecular Weight (Monoisotopic): 392.1485AlogP: 1.74#Rotatable Bonds: 4
Polar Surface Area: 95.60Molecular Species: NEUTRALHBA: 5HBD: 1
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 10.37CX Basic pKa: 3.89CX LogP: 1.15CX LogD: 1.15
Aromatic Rings: 3Heavy Atoms: 29QED Weighted: 0.54Np Likeness Score: -0.88

References

1. Governa P, Manetti F..  (2022)  Recent research results have converted gp120 binders to a therapeutic option for the treatment of HIV-1 infection. A medicinal chemistry point of view.,  229  [PMID:34992041] [10.1016/j.ejmech.2021.114078]

Source